Clinically, membrane and soluble CD48 expression increases under inflammatory conditions and has been shown to be elevated in patients with systemic inflammatory disorders, hematopoietic malignancies, infections, and allergic diseases [3, 8, 9, 11–13]. This evidence concerns the gene CD48 and infection.